Evidence map›Paper›PMID 37725357›Full record

ArticleRheumatology (Oxford, England)2024

Significant gastrointestinal unmet needs in patients with Systemic Sclerosis: insights from a large international patient survey.

Giulia Bandini, Alessia Alunno, Barbara Ruaro, Ilaria Galetti, Michael Hughes, Zsuzsanna H McMahan

Abstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Biomarkers in Systemic Sclerosis: An Overview.Current issues in molecular biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Giulia BandiniDepartment of Experimental and Clinical Medicine, Division of Internal Medicine, AOUC, University of Florence, Firenze, Italy.ORCID 0000-0002-2076-7319
Alessia AlunnoDepartment of Life Health and Environmental Sciences, Internal Medicine and Nephrology Division, ASL1 Avezzano-Sulmona-L'Aquila, University of L'Aquila, L'Aquila, Italy.ORCID 0000-0003-1105-5640
Barbara RuaroPulmonology Unit, Department of Medical Surgical and Health Sciences, University Hospital of Cattinara, University of Trieste, Trieste, Italy.
Ilaria GalettiFESCA (Federation of European Scleroderma Associations) Belgium, GILS (Gruppo Italiano, Lotta alla Sclerodermia (Italy), Milan, Italy.
Michael HughesDepartment of Rheumatology, Salford Care Organisation, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Zsuzsanna H McMahanDivision of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0001-6461-8940

Funding

Scleroderma and Gastrointestinal Disease: Insights into Clinical Phenotypes and Disease PathogenesisK23AR071473 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI MCMAHAN, ZSUZSANNA HORTOBAGYI · 2018 to 2022
$808k
NIAMS NIH HHS K23 AR071473NIH HHS 1K23AR071473
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Scleroderma, SystemicHumans

Identifiers

PMID37725357
PMCPMC10907805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.